LifeView™ PGT provides the most advanced genetic screening for the IVF embryo available. Studies comparing LifeView to conventional testing methods proved higher pregnancy rates and lower miscarriage rates.
A routine screening to determine if an embryo has the correct number of chromosomes.
Designed for those with an increased risk of passing monogenic disorders to their children.
This test is validated to reduce disease risk for your future child including heart disease, cancer, and diabetes.
Designed to screen for chromosome abnormalities caused by known structural rearrangements in a parent.
This test screens biological parents for a gene associated with increased miscarriage risk.